Advertisement
Liver, Pancreas and Biliary Tract|Articles in Press

Impact of sarcopenic obesity on predicting the severity of acute pancreatitis

Published:February 26, 2023DOI:https://doi.org/10.1016/j.dld.2023.02.002

      Abstract

      Background and aims

      This work aimed to evaluate the impact of sarcopenia and sarcopenic obesity on the occurrence of severe pancreatitis and to study the performance of anthropometric indices to predict severe forms.

      Methods

      We conducted a single-center retrospective study at Caen University Hospital between 2014 and 2017. Sarcopenia was assessed by measuring the psoas area on an abdominal scan. The psoas area /body mass index ratio reflected sarcopenic obesity. By normalizing the value to the body surface, we obtained an index called sarcopancreatic index, avoiding sex differences in measurements.

      Results

      Among 467 included patients, 65 (13.9%) developed severe pancreatitis. The sarcopancreatic index was independently associated with the occurrence of severe pancreatitis (1.455 95% CI [1.028–2.061]; p = 0.035), as was the Visual Analog Scale, creatinine or albumin. The complication rate was not different depending on sarcopancreatic index value. Based on variables independently associated with the occurrence of severe pancreatitis, we constructed a score called Sarcopenia Severity Index. This score presented an area under the receiver operating characteristics curve of 0.84, comparable to the Ranson score (0.87) and superior to body mass index or the sarcopancreatic index to predict a severe form of acute pancreatitis.

      Conclusions

      Sarcopenic obesity seems to be associated with severe acute pancreatitis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Peery A.F.
        • Crockett S.D.
        • Murphy C.C.
        • et al.
        Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018.
        Gastroenterology. 2019; 156 (e11): 254-272
        • De Campos T.
        • Cerqueira C.
        • Kuryura L.
        • et al.
        Morbimortality indicators in severe acute pancreatitis.
        JOP. 2008; 9: 690-697
        • Gapp J.
        • Hall A.G.
        • Walters R.W.
        • et al.
        Trends and outcomes of hospitalizations related to acute pancreatitis: epidemiology from 2001 to 2014 in the United States.
        Pancreas. 2019; 48: 548-554
        • Jung B.
        • Carr J.
        • Chanques G.
        • et al.
        [Severe and acute pancreatitis admitted in intensive care: a prospective epidemiological multiple centre study using CClin network database].
        Ann Fr Anesth Reanim. 2011; 30: 105-112
        • Mofidi R.
        • Duff M.D.
        • Wigmore S.J.
        • et al.
        Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis.
        Br J Surg. 2006; 93: 738-744
        • Schepers N.J.
        • Bakker O.J.
        • Besselink M.G.
        • et al.
        Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis.
        Gut. 2019; 68: 1044-1051
        • Banks P.A.
        • Bollen T.L.
        • Dervenis C.
        • et al.
        Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus.
        Gut. 2013; 62: 102-111
        • Dellinger E.P.
        • Forsmark C.E.
        • Layer P.
        • et al.
        Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation.
        Ann Surg. 2012; 256: 875-880
        • Papachristou G.I.
        • Muddana V.
        • Yadav D.
        • et al.
        Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis.
        Am J Gastroenterol. 2010; 105 (quiz 42): 435-441
        • Crockett S.D.
        • Wani S.
        • Gardner T.B.
        • et al.
        American gastroenterological association institute guideline on initial management of acute pancreatitis.
        Gastroenterology. 2018; 154: 1096-1101
        • Papachristou G.I.
        • Papachristou D.J.
        • Avula H.
        • et al.
        Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response.
        Pancreatology. 2006; 6: 279-285
        • Eros A.
        • Soos A.
        • Hegyi P.
        • et al.
        Sarcopenia as an independent predictor of the surgical outcomes of patients with inflammatory bowel disease: a meta-analysis.
        Surg Today. 2020; 50: 1138-1150
        • Kim G.
        • Kang S.H.
        • Kim M.Y.
        • et al.
        Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis.
        PLoS ONE. 2017; 12e0186990
        • Lieffers J.R.
        • Bathe O.F.
        • Fassbender K.
        • et al.
        Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery.
        Br J Cancer. 2012; 107: 931-936
        • Richards S.J.G.
        • Senadeera S.C.
        • Frizelle F.A
        Sarcopenia, as assessed by psoas cross-sectional area, is predictive of adverse postoperative outcomes in patients undergoing colorectal cancer surgery.
        Dis Colon Rectum. 2020; 63: 807-815
        • Xu J.Y.
        • Li C.
        • Zhang H.
        • et al.
        Total Psoas area index is valuable to assess sarcopenia, sarcopenic overweight/obesity and predict outcomes in patients undergoing open pancreatoduodenectomy.
        Risk Manag Healthc Policy. 2020; 13: 761-770
        • Olesen S.S.
        • Buyukuslu A.
        • Kohler M.
        • et al.
        Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis.
        Pancreatology. 2019; 19: 245-251
        • Sternby H.
        • Mahle M.
        • Linder N.
        • et al.
        Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissue.
        United European Gastroenterol J. 2019; 7: 1312-1320
        • van Grinsven J.
        • van Vugt J.L.A.
        • Gharbharan A.
        • et al.
        The association of computed tomography-assessed body composition with mortality in patients with necrotizing pancreatitis.
        J Gastrointest Surg. 2017; 21: 1000-1008
        • Vannier E.
        • Dupont-Lucas C.
        • Lagarde B.
        • et al.
        Development of a score for predicting severe acute pancreatitis at admission.
        Pancreas. 2022; 51: 128-134
        • Working Group IAPAPAAPG
        IAP/APA evidence-based guidelines for the management of acute pancreatitis.
        Pancreatology. 2013; 13: e1-15
        • Premkumar R.
        • Phillips A.R.
        • Petrov M.S.
        • et al.
        The clinical relevance of obesity in acute pancreatitis: targeted systematic reviews.
        Pancreatology. 2015; 15: 25-33
        • Smeets X.
        • Knoester I.
        • Grooteman K.V.
        • et al.
        The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis.
        Eur J Gastroenterol Hepatol. 2019; 31: 316-322
        • Yoon S.B.
        • Choi M.H.
        • Lee I.S.
        • et al.
        Impact of body fat and muscle distribution on severity of acute pancreatitis.
        Pancreatology. 2017; 17: 188-193
        • Cruz-Jentoft A.J.
        • Bahat G.
        • Bauer J.
        • et al.
        Sarcopenia: revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 16-31
        • Jones K.I.
        • Doleman B.
        • Scott S.
        • et al.
        Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications.
        Colorectal Dis. 2015; 17: O20-O26
        • Kalinkovich A.
        • Livshits G
        Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
        Ageing Res Rev. 2017; 35: 200-221
        • Boutin R.D.
        • Kaptuch J.M.
        • Bateni C.P.
        • et al.
        Influence of IV contrast administration on CT measures of muscle and bone attenuation: implications for sarcopenia and osteoporosis evaluation.
        AJR Am J Roentgenol. 2016; 207: 1046-1054
        • Khanna A.K.
        • Meher S.
        • Prakash S.
        • et al.
        Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI Scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis.
        HPB Surg. 2013; 2013367581